X73-17313-14578
4 vaccinations
1 coded response
45 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 991 / WA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
- 2021-01-11
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body achesAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
- 2021-07-14
-
2021-10-13
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-19
-
2021-10-20
Health check-in — day 7, dose 3Feeling: Good · Headache, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-11-17
- 2021-11-24
-
2022-01-12
Survey response — 3 months, dose 3MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: GoodFree text: Had a minor cold with a runny nose, cough, and slight sore throat. I tested negative for covid.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-13
-
2022-09-29
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-12-29
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-10-13 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-29 | Pfizer-BioNTech | Flu |
Free text
Release 10 — 3 months, dose 3
Symptoms: Had a minor cold with a runny nose, cough, and slight sore throat. I tested negative for covid.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release